Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 36 of Vanda Pharmaceuticals Inc.'s SEC filings and found 1 shelf registration on file for VNDA. The latest dilution event on file is a registration statement on May 5, 2026. Analysis updated Oct 31, 2026.
DilutionScan ProEvery instrument in full ยท $59/mo
Covered companies in Biotechnology. All tickers A to Z
KRROKorro Bio, Inc.
IMRXImmuneering Corporation
SLGLSol-Gel Technologies Ltd. Ordinary Shares
GLSIGreenwich LifeSciences, Inc.
PALIPalisade Bio, Inc.
IFRXInflaRx N.V. Common Stock
CABACabaletta Bio, Inc.
ELDNEledon Pharmaceuticals, Inc.
ABEOAbeona Therapeutics Inc.
FATEFate Therapeutics, Inc.
IKTInhibikase Therapeutics, Inc.
CAMPCAMP4 Therapeutics Corporation
ACIUAC Immune SA
PLXProtalix BioTherapeutics, Inc.
ARTVArtiva Biotherapeutics, Inc.